Synthesis and Biological Screening of 1,3-Dialkyl Derivatives of 4-(2’5-Dioxopyrrolidine-3-yl) Phenyl Sulphinic Acid as Inhibitors of Oestrone Sulphatase Steroid sulphatase Inhibitor
Iranian Journal of Pharmaceutical Sciences,
Vol. 2 No. 4 (2006),
1 October 2006
,
Page 215-224
https://doi.org/10.22037/ijps.v2.40324
Abstract
1,3-dialkyl 3-phenylpyrrolidine-2, 5-diones were modified to produce potential steroid sulphatase inhibitors. These modifications were aimed at producing compounds, which could be expected to bind reasonably well to the active site of the steroid sulphatase enzyme but could not be hydrolyzed readily by the enzyme due to the covalent S-C bond present. In this regard the sulphinic acid derivatives of di-substituted 3-phenylpyrrolidine-2, 5-diones were prepared. On biological testing, only compound 4-(2,5-dioxo-1, 3-dipentylpyrrolidine-3-yl) phenylsulphinic acid (F5) was found to be an inhibitor of the steroid sulphatase enzyme from human placenta and was about twice as potent as the known inhibitor danazol.
- Breast cancer
- Oestrone sulphatase
- Phenylpyrrolidine-2,5-dione
- Steroid sulphatase
How to Cite
References
[2] Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients: J Steroid Biochem Mol Biol 2003;86, 455-460
[3] Tilson-Mallett N, Santner SJ, Feil PD, Santen SJ. Biological significance of aromatase activity in human breast tumours. J Clinical Endocrinol Metabolism 1983; 57: 1125-8.
[4] Reed MJ, Owen AM, Lai LC, Coldham NG, Ghilchic MW, Shaikh NA, James VHT. In situ osterone synthesis in normal breast and breast tumour tissues: Effect of treatment with 4-hydroxyandrostenedione.Int J Cancer 1989; 44; 233-37.
[5] Santer SJ, Feil PD, Santen RJ. In situ oestrogen production via oestrone sulphatase pathway in breast tumours: Relative importance versus the aromatase pathway. J Clinical Endocrinol Metabolism 1984; 59: 29-33.
[6] Saito T, Kinoshita S, Fujii T, Bandoh K, Fuse S, Yamauchi Y, Koizumi N, Horiuchi T. Development of novel steroid sulfatase inhibitors:II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats. J Steroid Biochem Mol Biol 2004; 88:167-73.
[7] Reed MJ, Purohit A. Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev Endocrine-Related Cancer 1993;45: 51-62.
[8] Purdy RH, Engel LL, Oncley JL. The charactrisation of oestrone sulphate from human plasma. J Biolo Chem 1961; 236: 1043-50.
[9] Vignon F, Terqui M, Westley B, Derocq D,Rochefort H. Effects of plasma estrogen sulphatase in mammary cancer cells. Endocrinology 1980; 106: 1079-86.
[10] Purohit A, Woo LWL, Chander SK, Newman SP, Ireson C, Ho Y, Grasso A, Leese MP, Potter BVL, Reed MJ. Steroid sulphatase inhibitors for breast cancer therapy. J Steroid Biochem Mol Biol 2003; 86: 423-32.
[11] Prost O, Turrel M, Dahan N, Craveur C, Adessi GL. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate leveles in human breast carcinoma. Cancer Res 1984; 44:661-4.
[12] Purohit A, Reed MJ. Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast cancer cells: Modulation by steroidal and non-steroidal therapeutic agents. Int J Cancer 1992; 50: 901-5.
[13] Vihko P, Härkönen P, Soronen P, Törn S, Herrala A, Kurkela R, Pulkka A, Oduwole O, Isomaa V.17b-Hydroxysteroid dehydrogenases-their role in pathophysiology. Mol Cell Endocrinol 2004;215: 83-8.
[14] Duncan LJ, Purohit A, Howarth NM, Potter BVL,Reed MJ. Inhibition of estrone sulphatase activity by estrone-3-methylthiophosphonate: Apotential therapeutic agent in breast cancer. Cancer Res 1993; 53: 298-303.
[15] Whomsley R, Smith HJ, Nicholls PJ, Nazareth W,Ahmadi M. Some 1-, and 3-substituted 3-(4’-aminophenyl)pyrrolidine-2,5-diones as selective inhibitors of aromatase. J Enzyme Inhibition 1993; 6: 317-30.
[16] Hassanzadeh F. Design and synthesis of inhibitors of steroid sulphatase and 17beta-hydroxysteroid dehydrogenase as potential agents in the treatment of breast cancer. PhD Thesis, 1996, University of Wales.
[17] Daly MJ, Jones GW, Nicholls PJ, Smith HJ,Rowlands MG, Bunnett M. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpirolidine-2,5-dione. J Med Chem1986; 29: 520-3.
- Abstract Viewed: 86 times
- IJPS_Volume 2_Issue 4_Pages 215-224 Downloaded: 18 times